News from LabRulezLCMS Library - Week 52, 2025
LCMSArticle | Application

News from LabRulezLCMS Library - Week 52, 2025

This week we bring you application notes by Agilent Technologies, Metrohm, Shimadzu and Waters Corporation!
News from LabRulezLCMS Library - Week 52, 2025
News from LabRulezGCMS Library - Week 52, 2025
GCMSArticle | Application

News from LabRulezGCMS Library - Week 52, 2025

This week we bring you application notes by Agilent Technologies, EST Analytical and Shimadzu!
News from LabRulezGCMS Library - Week 52, 2025
A Christmas Gift for Clarity Users: A Free Tips & Tricks Webinar
GCMSLCMSArticle | Webinars

A Christmas Gift for Clarity Users: A Free Tips & Tricks Webinar

DataApex announces a free Clarity Tips & Tricks online webinar in January 2026, focusing on tips, tricks, and advanced features of Clarity Chromatography Software with emphasis on productivity and automation.
A Christmas Gift for Clarity Users: A Free Tips & Tricks Webinar
Innovations of 1975 and the Birth of the First Commercialized Suppressed Ion Chromatograph
LCMSArticle | Popularization

Innovations of 1975 and the Birth of the First Commercialized Suppressed Ion Chromatograph

The year 1975 marked a milestone with the launch of the first commercial suppressed ion chromatograph. This blog looks back at key innovations and their connection to ion chromatography.
Innovations of 1975 and the Birth of the First Commercialized Suppressed Ion Chromatograph
Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient’s Bioavailability
ICPMSScientific article | Science and research

Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient’s Bioavailability

Long-term administration of proton pump inhibitors affected mineral bioavailability and blood parameters in rats, suggesting risks of iron, calcium, and copper deficiency.
Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient’s Bioavailability
Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification
LCMSScientific article | Science and research

Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification

A validated QbD-based RP-HPLC method enables robust, stability-indicating impurity analysis of Elexacaftor, supporting process development and quality control in drug manufacturing.
Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification
Insecticide-Induced Perturbations in Sugar Metabolism and Alkaloid Biosynthesis in Coffea arabica (L.) Seedlings
GCMSScientific article | Science and research

Insecticide-Induced Perturbations in Sugar Metabolism and Alkaloid Biosynthesis in Coffea arabica (L.) Seedlings

GC–MS metabolomics revealed that soil-applied insecticides induce distinct metabolic changes in coffee seedlings, affecting sugar pathways and alkaloid biosynthesis beyond pest control.
Insecticide-Induced Perturbations in Sugar Metabolism and Alkaloid Biosynthesis in Coffea arabica (L.) Seedlings
Natural Product Discovery through Liquid Extraction Based Ambient ionization Mass Spectrometry
LCMSInterview | Video

Natural Product Discovery through Liquid Extraction Based Ambient ionization Mass Spectrometry

Interview with PhD researcher Jess on using ambient ionization mass spectrometry to screen and prioritize novel metabolites, reduce solvent use, and streamline natural product discovery before chromatography.
Natural Product Discovery through Liquid Extraction Based Ambient ionization Mass Spectrometry
The butterfly – a symbol of hope for oncology patients – chosen as the emblem of Taveren Therapeutics, a new biotech company emerging from IOCB Prague
LCMSICPMSGCMSArticle | Science and research

The butterfly – a symbol of hope for oncology patients – chosen as the emblem of Taveren Therapeutics, a new biotech company emerging from IOCB Prague

IOCB Prague is co-founding Taveren Therapeutics, a new biotech spin-off developing a novel cancer treatment strategy based on reactivating the body’s natural tumor suppressors.
The butterfly – a symbol of hope for oncology patients – chosen as the emblem of Taveren Therapeutics, a new biotech company emerging from IOCB Prague
PF 2026 Watrex Prague
GCMSLCMSArticle | Various

PF 2026 Watrex Prague

A heartfelt thank you to our customers and partners for their trust and cooperation, with warm wishes for a joyful Christmas and a successful, stable, and innovative year 2026.
PF 2026 Watrex Prague